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Abstract
Background: The feeding in the first months of the life seems to influence the risks of obesity and
affinity to some diseases including atherosclerosis. The mechanisms of these relations are unknown,
however, the modification of hormonal action can likely be taken into account. Therefore, in this
study the levels of ghrelin and orexin A - peripheral and central peptide from the orexigenic gut-
brain axis were determined.
Methods: Fasting and one hour after the meal plasma concentrations of ghrelin and orexin were
measured in breast-fed (group I; n = 17), milk formula-fed (group II; n = 16) and highly hydrolyzed,
hypoallergic formula-fed (group III; n = 14) groups, age matched infants (mean 4 months) as well as
in children with iv provision of nutrients (glucose - group IV; n = 15; total parenteral nutrition -
group V; n = 14). Peptides were determined using EIA commercial kits.
Results: Despite the similar caloric intake in orally fed children the fasting ghrelin and orexin levels
were significantly lower in the breast-fed children (0.37 ± 0.17 and 1.24 ± 0.29 ng/ml, respectively)
than in the remaining groups (0.5 ± 0.27 and 1.64 ± 0.52 ng/ml, respectively in group II and 0.77 ±
0.27 and 2.04 ± 1.1 ng/ml, respectively, in group III). The postprandial concentrations of ghrelin
increased to 0.87 ± 0.29 ng/ml, p < 0.002 and 0.76 ± 0.26 ng/ml, p < 0.01 in groups I and II,
respectively as compared to fasting values. The decrease in concentration of ghrelin after the meal
was observed only in group III (0.47 ± 0.24 ng/ml). The feeding did not influence the orexin
concentration. In groups IV and V the ghrelin and orexin levels resembled those in milk formula-
fed children.
Conclusion: The highly hydrolyzed diet strongly affects fasting and postprandial ghrelin and orexin
plasma concentrations with possible negative effect on short- and long-time effects on
development. Also total parenteral nutrition with the continuous stimulation and lack of fasting/
postprandial modulation might be responsible for disturbed development in children fed this way.
Background
The human milk is superior baby nutrient. Mother milk
has the right content of fat, sugar, water, and protein
required for a baby growth and development. An advan-
tage of the human milk over milk formulas is commonly
known. However, the milk formulas, products chemically
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resembling the natural human milk are sometimes in use.
Under certain circumstances, the enteral feeding is impos-
sible and all water, energy and body structure materials
are delivered directly to the vessels. In shorter periods of
the deprivation of enteral feeding, organism may be intra-
venously supplemented with the saline and glucose solu-
tions, but in longer periods of food deprivation, the
parenteral nutrition is required. The short-time and long-
time consequences of enteral and parenteral feeding are
not clear, especially for growing organisms.
Discovery of gastrointestinal peptides which influence the
central regulation of the food intake (directly or indirectly
via vagus nerve) provided establishing of a two-way con-
nection termed gut-brain axis [1]. Peripheral ghrelin and
mainly central orexins are involved in the orexigenic part
of this axis. Both these peptides stimulate the expression
and releasing of neuropeptide Y (NPY) - the central neu-
romediator in feeding behavior [2].
Ghrelin is a 28-amino acid peptide produced principally
in the stomach and small intestine [3]. Initially, ghrelin
was considered responsible for a growth hormone release
[4]. At the present, its role in the formation of eating
behavior and weight regulation was recognized. Ghrelin is
up-regulated in fasting, plasma ghrelin peaks before a reg-
ular meal, then progressively decreases. Its increase to
another peak value just before the next meal suggests that
ghrelin might act as a meal initiator [5]. Ghrelin, known
mainly as a short-time regulator, is also involved in a
long-term regulation. In respect to normal-weight individ-
uals, circulating levels of ghrelin are lower in obese and
elevated in anorectic patients. The levels of this peptide
negatively correlated with body mass index [6,7]. The
increase in ghrelin during starvation boosts eating behav-
ior, induces body weight gain and adiposity through stim-
ulating food intake and reducing fat utilization or energy
expenditure [8]. Intracerebraventricular administration of
ghrelin stimulates both growth hormone secretion and
food intake [9,10].
Orexins A (OXA) and B, 33 and 28 amino acid peptides,
respectively, originate from 130 amino acid preproorexin
produced by neurons located in the hypothalamus and in
the spinal cord [10-12]. However, neurons and endocrine
cells in the gut and pancreas also exhibit orexin-like
immunoreactivity [13]. The projection of central orexin
nerves in humans leads to locus coeruleus, dorsal raphe
nuclei, amygdala, suprachismatic nucleus, basal fore-
brain, cholinergic brainstem and spinal cord [14]. Orexins
are involved in developing behavior patterns controlled
by the hypothalamic region [15]. The Greek origin name
of these peptides clearly reflects basic function of orexins
(orexigenic peptides) - orexos means "to eat" - i. e. posi-
tive stimulation of energy balance. Similarly to ghrelin, a
single intracerebroventricular injection of OXA increased
caloric intake when administered during the light phase
but not at the beginning of the dark phase, indicating that
sensitivity to orexins might be controlled by circadian var-
iations [16]. Orexin neurons interact with hypothalamic
feeding pathways and monoaminergic/cholinergic cent-
ers, thus probably, linking energy balance with sleep/
wakefulness phases and they motivate food seeking [17].
The studies revealed that orexins cooperate also in regula-
tion of blood pressure and heart rate and release of some
hypothalamic hormones [18].
Ghrelin and orexins with some other peptides constitute
jointly an orexigenic part of gut-brain axis which inte-
grates and regulates the homeostasis of energy balance
and feeding [19]. Ghrelin stimulates feeding through NPY
and AgRP, orexigenic peptides co-localized in neurons of
the hypothalamic arcuate nucleus [20]. NPY fibers directly
project to orexin neurons [21]. Intracerebroventricular
injection of anti-orexin antiserum prior to the NPY injec-
tion significantly attenuated NPY-induced feeding, indi-
cating that NPY interacts with orexins anatomically and
functionally [22]. There are suggestions that ghrelin partly
employs vagal afferent loops [23]. The next, central mes-
sengers, orexins A and B, are stimulated also with glucose.
Type of feeding within first months of the life has a great
impact upon obesity in the subsequent life periods and
can produce even long-life effects [24]. Breast-feeding of
newborns and infants improves lipid profile and lowers
blood pressure in later life and decreases the risk of devel-
oping obesity [25-28]. Likely, the way of feeding alters the
gut-brain axis and generates short and long term differ-
ences in the infant development. Also a deprivation of
enteral feeding by substituting it with a parenteral nutri-
tion may negatively influence the gut-brain axis. Although
orexins and ghrelin were discovered over 10 years ago, no
data are available on the influence of the diet used in the
infants' nutrition upon the secretion of ghrelin and OXA.
The bypassing of the gut which should result in the strong
disturbances in the secretion of hormones involved in the
gut-brain axis also remains unrecognized. Fasting and
postprandial plasma levels of ghrelin and OXA in nursed
infants, formula-fed infants, babies maintained on a
hypoallergic highly hydrolyzed diet or children on total
parenteral nutrition were determined in this study.
Methods
Experimental groups
The enterally fed children were divided into the following
groups: breast-fed infants (group I; n = 17, 10 girls and 7
boys) and cow milk formula-fed infants i.e. with Bebilon
1, Nutricia - formula for younger infants, equal to
Nutrilon 1; (group II; n = 16, 9 girls and 7 boys). All these
children were healthy. Group III (n = 14, 7 girls and 7BMC Gastroenterology 2009, 9:92 http://www.biomedcentral.com/1471-230X/9/92
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boys) consisted of infants allergic to milk protein and,
therefore, fed with the highly hydrolyzed milk protein for-
mula diet (Nutramigen; Bristol Myers Squibb & Mead
Johnson). The diagnosis of cow milk allergy (CMA) was
issued based on typical symptoms observed on former
physical examinations. The plasma levels of specific anti-
CMA IgE antibodies determined for a majority of children
from group III were pathologically elevated, although
only the children without physical symptoms of allergy at
least within two weeks before the study, were qualified to
the study. In all these children the diet remained
unchanged for at least two weeks before the test, and in
group III that period lasted at least 4 weeks. The children
were of similar age (group I - 3.5 ± 1.5 months; group II -
4 ± 1 month, group III - 4 ± 1.5 months). Mean body mass
was appropriate to the age and length (group I - 6.2 ± 0.9
kg; group II - 5.5 ± 0.8 kg, group III -5.6 ± 1.0 kg). Coex-
istence of other diseases and any hereditary connections
were excluded in all the subjects.
Children from group I received breast at any signs of hun-
ger - they were nursed 7-8 times a day. Children from
groups II and III received bottle usually 7 times a day also
when they showed signs of hunger. In all cases the diet did
not change for at least 2 weeks prior to the blood test sam-
pling. The calorie intake was adequate to the children age
and body weight. All infants were fed exclusively with
either milk or formula free of solids or mixed solids.
The children in group IV (n = 15, 6 girls and 9 boys) were
prepared for computed tomography in sedation and,
therefore, they were deprived of food for at least 8 hours
prior to the imaging. In this period they received fluids
(0.9% saline and 5% glucose mixture 2:1 vv) in the vol-
ume following their specific requirements for fluids.
Finally recruited children were free of pathologies. The
group V (n = 14, 6 girls and 8 boys) included infants
requiring a total parenteral nutrition for either congenital
atresia or acquired obstruction of gastrointestinal tract.
The children with total parenteral nutrition fully met their
amino acid requirements (Vaminolact, Fresenius Kabi).
The level of administered non-protein calories i.e. 70%
glucose, 30% lipid emulsion (Intralipid) was calculated
based on the amount of infused amino acids (175 kcal of
non-proteins per 1 gram of amino acid nitrogen).
Protocol of the study
The Permanent Ethical Committee for Clinical Studies of
the Medical College of the Jagiellonian University has
approved the protocol of the study, and the parents of
examined children provided their signed consent. Before
feeding, naked children were examined and weighted
with an electronic integrating balance. The crown-to-heel
length was measured with the 1 mm precision on a
recumbent infant board. Percentage of ideal body weight
was calculated using adequate data for the Polish popula-
tion [29].
The catheter was fixed in vein of each child and venous
blood was taken directly prior to the meal. Subsequently,
children consumed a portion of either milk or formula,
and the blood samples were collected 60 minutes after
this stimulation. For all groups, the mean volume of
either milk or milk formulas ingested per day was 620 ±
120 ml. The consumption lasted no longer than 30 min-
utes (mean 16 min). In children with total parenteral
nutrition the blood was taken once, after minimum 24 h
continuous infusion. In children with intravenous glucose
infusion, blood was collected also once after minimum 8
h continuous infusion.
Blood samples for the hormone determination were col-
lected into chilled glass tubes with 4 mg EDTA and 0.2
TIU (trypsin inhibitor unit) of aprotinin (Sigma, USA).
Immediately after the sampling, the tubes were trans-
ported to the laboratory in an icebox. Blood was centri-
fuged for 10 min at 3000 g and +4°C. Plasma was stored
at -80°C until the measurements. Ghrelin (total) as well
as OXA were determined with the EIA method (Phoenix
Pharmaceuticals, Inc, USA). The glucose levels were deter-
mined in serum using method with glucose oxidase.
In all estimations the intraassay coefficient of variation
was below 5%. The OXA assay exhibited 18% cross-reac-
tivity with orexin B and no cross-reactivity with other sub-
stances, such as NPY, MSH, leptin or CRP. Sensitivity of
the OXA assays was 0.06 ng/ml. The ghrelin kit had no
cross-reactivity with any other peptides. This method
offered the minimum detectable concentration of ghrelin
as low as 0.08 ng/ml.
Differences between groups were tested for statistical sig-
nificance involving one-way analysis of variance followed
by the Bonferroni multiple comparison procedure or,
when appropriate, by Student's t-test (paired when com-
pared parameters before and after feeding in the same
group). Parametric and non-parametric Spearman rank
correlations were used to evaluate relations between dif-
ferent variables. P ≤ 0.05 was considered significant.
Results
There were no statistical differences in the age and body
weight between studied groups (table 1). For the breast-
fed children uptake of 108 kcal/kg/24 h was accepted as
recommended value of daily energy intake for 4 month
children in the Guideline of the Polish National Food and
Nutrition Institute. The consumption of energy in groups
II and III was calculated from the volume of ingested for-
mulas within 24 hours, taking into account the body
weight and energetic value of consumed milks reported byBMC Gastroenterology 2009, 9:92 http://www.biomedcentral.com/1471-230X/9/92
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the manufacturers. The children fed with primary formula
based on cow milk consumed mainly 108 ± 18 kcal/kg/24
h, and children fed with highly hydrolyzed protein for-
mula consumed 108 ± 22 kcal/kg/24 h. The calorie intake
in these groups was almost like one another and signifi-
cantly higher than in children fed parenterally (p <
0.001). Children with TPN received 60 ± 8 kcal/kg/24 h,
whereas children maintained on iv saline/glucose mixture
received only 37 ± 6 kcal/kg/24 h.
There were no differences in the fasting glucose levels
(group I - 5.0 ± 0.4 mmol/l, II - 4.7 ± 0.3 mmol/l and III -
4.8 ± 0.4 mmol/l). Also one hour after the meal there were
no differences between groups in the glucose concentra-
tion (I - 5.2 ± 0.5 mmol/l; II - 5.1 ± 0.8 mmol/l; III - 5.5 ±
1.1 mmol/l) (figure 1), however in every group postpran-
dial glucose levels were significantly higher than fasting
levels (Student's paired test). In children with intravenous
infusion of glucose and crystalloids and on the total
parenteral nutrition, the mean glucose levels were similar
(4.7 ± 1.2 mmol/l and 5.7 ± 1.4 mmol/l, respectively).
Concentration of ghrelin in group I before the meal was
lower (0.37 ± 0.17 ng/ml) than in groups II (0.5 ± 0.27
ng/ml) and III (0.77 ± 0.27 ng/ml; p < 0.005). It is inter-
esting, that in groups I and II within 1 hr after feeding,
ghrelin increased over the fasting value to 0.87 ± 0.29 ng/
ml, p < 0.002 and 0.76 ± 0.26 ng/ml, p < 0.01, respec-
tively. The decrease in the concentration of ghrelin after
the meal was observed only in group III (0.47 ± 0.24 ng/
ml). In groups IV and V, the ghrelin levels were similar
(0.69 ± 0.3 ng/ml and 0.73 ± 0.3 ng/ml, respectively) and
resembled these observed in nursed children (figure 1).
The mean values of the OXA level in group I before (1.24
± 0.29 ng/ml) and 1 hr. after the meal (1.38 ± 0.4 ng/ml)
were significantly lower (p < 0.02) than the mean OXA
concentrations in group II (1.64 ± 0.52 ng/ml and 1.76 ±
0.59 ng/ml, respectively) and in group III (2.04 ± 1.1 ng/
ml and 2.02 ± 0.8 ng/ml, respectively). In groups IV and
V, the OXA levels were similar (1.75 ± 0.53 ng/ml and
1.89 ± 0.89 ng/ml, respectively) and resembled these
observed in the milk formula fed children (figure 1)
Correlations
There were no significant correlations between analyzed
parameters employing non-parametric Spearman test in
all studied children. However, in subsequent groups a sig-
nificant correlations were found between glucose and
ghrelin. They were positive in children fed with milk and
negative in children fed with highly hydrolyzed formula
(table 2).
Discussion
Several experiments showed that ghrelin and orexins stim-
ulate hyperphagia and they strongly participated in the
short-term as well as in the long-term energy balance [30-
33]. Up to date, few papers analyzed the influence of the
type of feeding on the fasting ghrelin outcome in few
months period [34-36]. The direct effect of different for-
mulas on fasting and postprandial ghrelin as well as anal-
ysis of ghrelin together with OXA as a part of gut-brain
axis have not been reported. In this study, the response of
glucose, ghrelin and OXA to a single oral bolus of formu-
las used in the infants' nutrition, as well as in the parenter-
ally fed babies has been investigated.
Orally fed children
Fasting glucose in orally fed groups was almost the same.
One hour after the feeding, the blood glucose levels were
higher than on fasting and its levels were similar in all
studied groups. In spite of these similarities, the signifi-
cant differences were noted in the fasting and postpran-
dial plasma concentrations of ghrelin and orexin. The
fasting ghrelin and orexin levels were the lowest in the
breast-fed children, and the highest levels of those pep-
tides were observed in the children fed with highly hydro-
lyzed diet. Similar results reported Savino et al. [36]. They
found that the fasting ghrelin values were lower in the
nursed babies than in formula-fed infants, however, the
Table 1: Clinical characteristics of studied children groups expressed as mean ± SD.
Group Food Age (months ± SD) Body weight (kg ± SD)
Number Population (n)
I 17 Human milk 3.5 ± 1.5 6.2 ± 0.9
II 16 Cow milk primary formula (Bebilon 1) 4 ± 1 5.5 ± 0.8
III 14 Highly hydrolyzed protein formula (Nutramigen) 4 ± 2 5.6 ± 1.0
IV 15 Infusion of glucose/saline mixture 4.5 ± 1.5 6.3 ± 1.9
V 14 Total parenteral nutrition 4 ± 2 4.9 ± 1.8BMC Gastroenterology 2009, 9:92 http://www.biomedcentral.com/1471-230X/9/92
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The mean concentrations of ghrelin, orexin and glucose Figure 1
The mean concentrations of ghrelin, orexin and glucose. The levels of determined parameters before meal (groups IA, 
IIA, IIIA), one hour after the meal (groups IB, IIB, IIIB) and in parenterally fed groups IV and V. The differences in one parameter 
between the same group before and after the meal (paired t-test) are marked with asterisks (* = p < 0.05; ** = p < 0.001).
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difference, was statistically insignificant in children over 4
month old [36].
One hour after the feeding, the concentrations of ghrelin
in plasma were opposite to these in the fasting state. The
ghrelin levels were the lowest in the children fed with
highly hydrolyzed diet, and the highest level of this pep-
tide was recorded in the breast-fed children. Although the
energy intake in the ingested food was the same, the food
differed in its composition, especially in the degree of
hydrolysis of the proteins and carbohydrates and the level
of ghrelin. According to Aydin et al. [37], ghrelin is
present in the human milk and its concentration increases
with the duration of lactation, however, the concentration
of ghrelin in plasma is almost twice as high as in milk
[37]. Taking into account the relatively high ratio of the
volume of the nursed milk to the volume of infants blood,
the higher levels of postprandial ghrelin in breast-fed chil-
dren might result from exogenous delivery of this peptide
from the mother milk. The impact of ingested (exoge-
nous) peptides on the infants development has not been
recognized yet.
An increase in the ghrelin levels after nursing might have
an alternative explanation. The serum ghrelin concentra-
tions increase on fasting and decrease after the meals [38].
However, decrease in postprandial ghrelin is not immedi-
ate. It can take up to 2 hours after meals [39,40]. In con-
trast to adults, ghrelin refractoriness to inhibition by food
intake in children should reflect a peculiar functional pro-
file of ghrelin in childhood [41]. The ghrelin in childhood
is oriented to anabolic functions i. e. stimulation of the
feeding behavior. The long-lasting high ghrelin levels after
the meal in breast-fed children seem advantageous
because it might support a development of so fed babies
[42,43]. Additionally, the ghrelin plasma levels are related
to maturation of the ghrelin production in the stomach.
An increase in the ghrelin secretion during the first
months of the life probably prepare the babies to differen-
tiation of food, and specially to the solid food ingestion
[43]. In this case the higher and longer lasting ghrelin lev-
els - as observed in breast-fed babies - might be extremely
beneficial.
The fasting OXA levels mimic the pattern of ghrelin.
Plasma levels of orexins decrease with age and it could be
related to the energy requirement (per kg body weight)
[44]. The tested children received the same amount of
energy and, therefore, differences of the OXA concentra-
tion might resulted from the disturbances in the hunger-
satiety signaling, especially in the case of highly hydro-
lyzed diet.
The plasma levels of OXA one hour after the feeding were
similar to these observed in the fasting state, except the
breast-fed children showing postprandial increase in its
concentration (p < 0.05, paired t-test), (figure 1). Plasma
concentrations of OXA in adults increased on fasting and
decreased after the meal [45]. The higher levels of OXA in
the breast-fed children after the meal than prior to feeding
might be considered in terms of the presence of OXA in
human milk, but there is no evidence for secretion of
orexins to the milk in humans. A specific stimulation of
the gut with the human milk could offer another explana-
tion, because orexin-positive neurons are localized not
only in the hypothalamus, but also in the gastrointestinal
tract [46]. A stimulation of OXA secretion with ghrelin
could also be taken into account. Under such circum-
stances, the elevated postprandial ghrelin observed in
breast-fed children levels would be responsible for a
higher OXA output. However, in nursed babies and the
cow milk formula-fed groups, the correlation between
OXA and ghrelin was statistically insignificant.
Natural nursing is the gold standard in the infants' nutri-
tion in the first months of their life. Therefore, all compar-
isons should be performed for the breast-fed babies. The
present study revealed that the type of infant feeding
influence concentrations of ghrelin and OXA in the
plasma. Humanized cow milk is not equivalent to the
human milk, but provides hardly the close resemblance.
Therefore, it is not surprising that the ghrelin and OXA
responses are similar to the physiological effect of the
human milk ingestion. The significant differences in fast-
ing and also postprandial plasma levels of OXA and ghre-
lin as compared to nursed children were observed in the
children fed with highly hydrolyzed diet. In this group of
Table 2: Correlations coefficients between studied parameters in particular groups.
Group Breast-fed Cow milk formula Highly hydrolyzed formula Glucose-saline iv Total parenteral nutrition
Glucose/OXA 0.07 -0.48 * -0.02 -0.02 0.21
Glucose/ghrelin 0.47 * 0.32 * -0.43 * -0.16 0.29
OXA/ghrelin 0.18 0.12 -0.49 * -0.03 -0.21
* p < 0.05BMC Gastroenterology 2009, 9:92 http://www.biomedcentral.com/1471-230X/9/92
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children, the concentration of ghrelin negatively corre-
lated with the glucose concentrations. All these data fitted
well the observations that infants with small weight gain
over the first year of their life have lower ghrelin levels
after an intravenous glucose load [47]. Also Savino [35]
found negative correlation between fasting plasma ghre-
lin concentrations and infant weight gain, suggesting that
ghrelin concentration seems to be higher when infant
growth is slower [35]. Thus, results of the present study
support suggestions that children fed with the highly
hydrolyzed formulas might face disturbed short-time
development [48,49]. Prolonged application of the highly
hydrolyzed formula might result in setting the basal and
post stimulus levels of orexigenic peptides in points differ-
ent from these essential for children fed with either
human milk or cow milk formula. Long-term perspective
studies would be required to elucidate real consequences
of different diets applied.
In this group of children the concentration of ghrelin neg-
atively correlated also with the concentrations of OXA. It
is known, that secretion of OXA is controlled by ghrelin
[22]. Likely, in the children on the highly hydrolyzed diet
not only the secretion of ghrelin but also the relation
between ghrelin and OXA is perturbed.
It should also be taken into account that the postprandial
changes in the ghrelin and OXA secretion in highly-hydro-
lyzed formula (Nutramigen) -fed group might be devel-
oped faster than in other studied children. Nutramigen is
based on highly hydrolyzed milk casein with addition of
simple amino acids and glucose polymers. The digestion
of such a mixture is fast, and, therefore, uptake of amino
acids might elicit rapid stimulation of ghrelin secretion
and faster decrease in the ghrelin plasma concentration
[50]. Possible changes might be omitted in the "two-point
blood sampling" study.
Parenterally fed children
There are hardly few papers describing effects of the
parenteral nutrition on hunger and satiation, and pre-
sented results are contradictory because of the complexity
of the problem [51,52]. Several interfering factors such as
age of the patients and its caloric needs, the primary ill-
nesses, the duration of parenteral therapy per se, duration
of infusion per day and, the most important, the ratio
between parenteral and enteral energy delivery should be
taken into account. In the course of this study, solely
infants on complete parenteral provision of calories (total
parenteral nutrition - TPN) were tested. The infusions
were provided in around the clock schedule, to cover the
calorie needs and decrease potential metabolic (acidosis)
and clinic side effects (venous inflammation). Despite of
differences in the calorie load there were no significant
differences in the plasma levels of glucose, ghrelin and
OXA in the children receiving solely glucose intravenous
infusion and the children on total parenteral nutrition.
However, the concentrations of the determined peptides
were slightly higher in the TPN children, probably due to
higher calorie provision and/or presence of amino acids
and lipids in the infused fluids. Moreover, the concentra-
tions of orexigenic peptides in these groups resembled the
postprandial concentrations of ghrelin and OXA in the
children fed with the cow milk formula. The observation
that parenteral nutrition evoked changes in the orexigenic
peptides such as oral bolus in patients on enteral nutrition
agrees with the data in the sole paper on the subject pub-
lished by Murray et al. [46] who analyzed ghrelin in
parenterally fed humans. Data on OXA in parenterally fed
humans are unavailable. In that experiment with adult
patients, ghrelin levels markedly declined in course of
either parenteral nutrition or dextrose infusions reaching
values similar to the postprandial concentrations [52].
As shown in this study, the ghrelin and orexin plasma
concentrations during the TPN mimics the postprandial
levels observed in enterally fed children. A constant stim-
ulation with no intrameal modulation of ghrelin and
OXA secretion could be most harmful for children fed
parenterally for a long time. As recorded by Bonifacio et
al. [53], in the patients on long-term parenteral nutrition,
BMI increased year by year [53]. This phenomenon might
be related to the continuous stimulation of the secretion
of orexigenic peptides and their anabolic properties,
observed in the present study.
Feeding in early life - long-term consequences - focus on 
obesity
Energy balance is efficiently regulated in the short- and
long-term feedback. However, some differences in set-
point of secretion of central and peripheral signals in the
early stages of life might be crucial in the weight outcome
in the further life. The neonatal and infant period might
be considered as a new 'orexigenic' condition setting the
point or providing programming of ghrelin and even the
whole orexigenic regulation. The concept that nutrition in
the infancy could have a long-term influence on adiposity
and even program it was formulated in the 60'ties of the
past century [54]. The beginning of the enteral feeding
determines consequences for the regulation of orexigenic
(and anorexigenic) factors, especially, when it is superim-
posed with the type of the feeding. This idea - very difficult
to prove - is supported by several facts. It has been shown
that maternal prepregnant body mass index, the duration
of breastfeeding, and the timing of complementary food
introduction are associated with the infant weight gain
from the birth to the first year of life. Also healthy infants
with higher cord leptin levels at birth gain weight more
slowly over the period from their birth up to 4 months
[55,56]. The influence of early nutrition on a long-termBMC Gastroenterology 2009, 9:92 http://www.biomedcentral.com/1471-230X/9/92
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adiposity has already been shown [51]. It focused on the
possible protective role of the breastfeeding and the differ-
ences in the development between breast-fed and for-
mula-fed infants [57].
Present study showed that these disturbances involve not
only fasting plasma ghrelin levels but also plasma concen-
tration of OXA and postprandial secretion of ghrelin and
OXA. Observed discrepancies might be related to some
longitudinal effects upon the development or disease in
the further life. It is well documented by meta-analysis
that breast-fed children have a lower risk of elevated
weight gain in the further life [58-62], Some studies sug-
gested a longitudinal effect of nutrition in early life on the
adult atherosclerosis [63,64]. The hypothesis on the adi-
posity programming with the type of feeding based
mainly on chemical constitution of the human milk and
absence of some bioactive nutrients in formulas [65].
These specific components either set points or pro-
gramme of the basal/fasting and postprandial concentra-
tion or secretion of hormones and bioactive peptides. As
shown in this study, there was a significant difference in
fasting and postprandial ghrelin and OXA levels in differ-
ently fed infants. It could be hypothesized that the feeding
in the early live set the point of gut-brain orexigenic axis
and that it was responsible for several longitudinal effects
indicated above. Taking into account the ghrelin and OXA
concentrations observed in this study in breast-fed and
formula-fed infants, in our opinion the cow milk formula
slightly affected the orexigenic axis. The infants fed with
the highly hydrolyzed formula the most distinguished
from the other groups in the secretion of peptides
involved in this study, even when the group with the
parenteral nutrition was included in the comparison.
High fasting concentration of ghrelin might be associated
with a stronger feeling of hunger. The fixed tendency to
higher fasting ghrelin levels should provide a greater risk
of obesity in further life. The low postprandial concentra-
tion of ghrelin related, probably, to a fast down-regula-
tion of the post-stimulus secretion also might lead to
obesity. Therefore, the improper secretion of these two
anabolic peptides should be taken into account as possi-
ble factors inducing disturbances in development.
Conclusion
The highly hydrolyzed diet strongly affects fasting and
postprandial ghrelin and orexin plasma concentrations
with possible negative effect upon short- and long-time
effects in the development. The continuous stimulation
and lack of fasting/postprandial modulation of ghrelin
and orexin concentrations might be responsible for dis-
turbed development of parenterally fed children.
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